These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6121522)

  • 21. [Pharmacokinetics and pharmacodynamics of vecuronium and pancuronium in anesthetized man].
    Yajima C; Sugai N; Inada Y
    Masui; 1985 Sep; 34(9):1245-51. PubMed ID: 2868137
    [No Abstract]   [Full Text] [Related]  

  • 22. Uptake and excretion of vecuronium bromide and pancuronium bromide in the isolated perfused rat liver.
    Bencini AF; Mol WE; Scaf AH; Kersten UW; Wolters KT; Agoston S; Meijer DK
    Anesthesiology; 1988 Oct; 69(4):487-92. PubMed ID: 2902816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The interaction between vecuronium (NC 45) and pancuronium or d-tubocurarine in the rat phrenic nerve-hemidiaphragm preparation].
    Amaki Y; Koyama T; Tanaka K; Kobayashi K
    Masui; 1984 Oct; 33(10):1137-40. PubMed ID: 6151603
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical studies on Org NC 45: comparison with pancuronium.
    Kerr WJ; Baird WL
    Br J Anaesth; 1982 Nov; 54(11):1159-65. PubMed ID: 6128012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vecuronium (ORG NC-45) for laparoscopy. Clinical experience.
    Fragen RJ; Booij LH; Crul JF
    Acta Anaesthesiol Belg; 1982; 33(3):177-81. PubMed ID: 6128861
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of the neuromuscular blocking properties of ORG NC 45 and pancuronium in the rat, cat and rhesus monkey.
    Durant NN; Houwertjes MC; Crul JF
    Br J Anaesth; 1980 Aug; 52(8):723-30. PubMed ID: 6107096
    [No Abstract]   [Full Text] [Related]  

  • 27. Paradoxical antagonism of neuromuscular block by vecuronium metabolites.
    Ohta Y
    Acta Med Okayama; 1985 Dec; 39(6):471-80. PubMed ID: 2868610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the effects of Org NC 45 and pancuronium bromide on heart rate and arterial pressure in anaesthetized man.
    Barnes PK; Smith GB; White WD; Tennant R
    Br J Anaesth; 1982 Apr; 54(4):435-9. PubMed ID: 6121570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The circulatory effects of Org NC 45 (Norcuron) on three different anesthetic methods in patients with healthy hearts].
    Riegler R; Fitzal S
    Anaesthesist; 1984 Aug; 33(8):363-5. PubMed ID: 6148905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ORG NC 45.
    Miller RD
    Br J Anaesth; 1980; 52 Suppl 1():71S-72S. PubMed ID: 6107115
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.
    Ali HH; Savarese JJ; Basta SJ; Sunder N; Gionfriddo M
    Br J Anaesth; 1983; 55 Suppl 1():107S-111S. PubMed ID: 6134539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the effects of pancuronium bromide and its monoquaternary analogue, ORG NC 45, on autonomic and somatic neurotransmission in the rat.
    Docherty JR; McGrath JC
    Br J Pharmacol; 1980; 71(1):225-33. PubMed ID: 6110454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetics and pharmacodynamics of vecuronium in children].
    Steinbereithner K; Fitzal S; Schwarz S; Gilly H; Semsroth M; Weindlmayr-Goettel M
    Cah Anesthesiol; 1984; 32(1):5-10. PubMed ID: 6152193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of portacaval shunt and/or renal vessel ligation on disposition of muscle relaxants].
    Aoki T
    Masui; 1986 Mar; 35(3):428-39. PubMed ID: 2872346
    [No Abstract]   [Full Text] [Related]  

  • 35. The relationship between disposition and duration of action of congeneric series of steroidal neuromuscular blocking agents.
    Agoston S; Crul EJ; Kersten UW; Houwertjes MC; Scaf AH
    Acta Anaesthesiol Scand; 1977; 21(1):24-30. PubMed ID: 842267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC45) and pancuronium in anesthetized humans.
    Cronnelly R; Fisher DM; Miller RD; Gencarelli P; Nguyen-Gruenke L; Castagnoli N
    Anesthesiology; 1983 May; 58(5):405-8. PubMed ID: 6132566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evaluation of Org NC 45 (vecuronium) in paediatric anaesthesia.
    Ferres CJ; Crean PM; Mirakhur RK
    Anaesthesia; 1983 Oct; 38(10):943-7. PubMed ID: 6139042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The emergence of ORG NC 45, 1- [2 beta,3 alpha,5 alpha,16 beta,17 beta)-3, 17-bis(acetyloxy)-2-(1-piperidinyl)-androstan-16-yl]-1-methylpiperidinium bromide, from the pancuronium series.
    Savage DS; Sleigh T; Carlyle I
    Br J Anaesth; 1980; 52 Suppl 1():3S-9S. PubMed ID: 6107102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the relaxant and autonomic effects of pancuronium and its monoquaternary derivative Organon NC 45 in the pithed rat [proceedings].
    Docherty JR; McGrath JC
    Br J Pharmacol; 1980 Jan; 68(1):140P-141P. PubMed ID: 6101973
    [No Abstract]   [Full Text] [Related]  

  • 40. Interactions between the neuromuscular blocking drug Org NC 45 and some anaesthetic, analgesic and antimicrobial agents.
    McIndewar IC; Marshall RJ
    Br J Anaesth; 1981 Aug; 53(8):785-92. PubMed ID: 6115660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.